France
Remedee Labs is a Health Care and Medical Devices startup based in France, founded in 2016. The company's slogan, "Redefining Life with Chronic Pain," reflects its mission to enhance the lives of the 1.5 billion people worldwide who suffer from chronic pain, with over half of them dissatisfied with their current care.
Employing a patient-centric digital service platform, Remedee Labs has developed the first endorphin stimulator for personal use, a result of a decade of pre-clinical and clinical research. Leveraging its unique technology, the company aims to provide comprehensive chronic pain management and collaborate closely with medical practitioners.
Notably, Remedee Labs secured a €12.20M Series A investment on 06 December 2022, with backing from a consortium of notable investors including Bpifrance, C4 Ventures, Supernova Invest, BNP Paribas, Caisse d'Epargne Rhone Alpes, Partech, Banque Hottinguer, Generali France, Banques Populaires, and Artois Investment.
